L.B. Mellett

711 total citations
32 papers, 551 citations indexed

About

L.B. Mellett is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, L.B. Mellett has authored 32 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Physiology. Recurrent topics in L.B. Mellett's work include Pain Mechanisms and Treatments (4 papers), Neuropeptides and Animal Physiology (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). L.B. Mellett is often cited by papers focused on Pain Mechanisms and Treatments (4 papers), Neuropeptides and Animal Physiology (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). L.B. Mellett collaborates with scholars based in United States. L.B. Mellett's co-authors include L.A. Woods, Robert L. Dedrick, Donald L. Hill, Robert F. Struck, J. N. Cannon, Raymond L. Furner, Marion Kirk, Carl C. Hug, C. A. Schneyer and Robert F. Pittillo and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

L.B. Mellett

31 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.B. Mellett United States 14 178 118 114 59 55 32 551
Raymond L. Furner United States 14 246 1.4× 105 0.9× 139 1.2× 29 0.5× 49 0.9× 29 629
J Raaflaub Switzerland 15 292 1.6× 54 0.5× 92 0.8× 28 0.5× 53 1.0× 36 691
Leonard J. Lerner Malaysia 15 232 1.3× 148 1.3× 54 0.5× 41 0.7× 96 1.7× 49 1.0k
Leon Moore United States 15 308 1.7× 101 0.9× 159 1.4× 70 1.2× 30 0.5× 26 680
Hilton A. Salhanick United States 19 262 1.5× 60 0.5× 204 1.8× 30 0.5× 34 0.6× 53 935
Joseph Krasner United States 15 175 1.0× 56 0.5× 151 1.3× 23 0.4× 45 0.8× 40 600
B Catanese Italy 14 139 0.8× 60 0.5× 76 0.7× 13 0.2× 105 1.9× 50 474
Morris S. Zedeck United States 14 223 1.3× 171 1.4× 65 0.6× 67 1.1× 46 0.8× 33 657
D W Yesair United States 12 185 1.0× 191 1.6× 76 0.7× 31 0.5× 141 2.6× 27 566
Raymond H. Menard United States 16 358 2.0× 72 0.6× 328 2.9× 28 0.5× 43 0.8× 24 1.1k

Countries citing papers authored by L.B. Mellett

Since Specialization
Citations

This map shows the geographic impact of L.B. Mellett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.B. Mellett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.B. Mellett more than expected).

Fields of papers citing papers by L.B. Mellett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.B. Mellett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.B. Mellett. The network helps show where L.B. Mellett may publish in the future.

Co-authorship network of co-authors of L.B. Mellett

This figure shows the co-authorship network connecting the top 25 collaborators of L.B. Mellett. A scholar is included among the top collaborators of L.B. Mellett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.B. Mellett. L.B. Mellett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grebow, Peter E., et al.. (1977). Indapamide: Measurement by a Fluorescence Assay. Current Medical Research and Opinion. 5(sup1). 9–12. 3 indexed citations
2.
Dedrick, Robert L., et al.. (1977). A model for the kinetics of distribution of actinomycin-D in the beagle dog.. Journal of Pharmacology and Experimental Therapeutics. 200(3). 469–478. 31 indexed citations
3.
Furner, Raymond L., et al.. (1976). A method for the measurement of L-phenylalanine mustard in the mouse and dog by high-pressure liquid chromatography.. Drug Metabolism and Disposition. 4(6). 577–583. 40 indexed citations
4.
Furner, Raymond L., L.B. Mellett, & Thomas Herren. (1975). Influence of tetrahydrouridine on the phosphorylation of 1-beta-D-arabinofuranosyl-cytosine (ara-C) by enzymes from solid tumors in vitro.. Journal of Pharmacology and Experimental Therapeutics. 194(1). 103–110. 7 indexed citations
5.
Schneyer, C. A., et al.. (1975). Unexpected   Adrenergic Effects of the Antitumor Agent, Cyclocytidine, on Rat Salivary Glands. Experimental Biology and Medicine. 148(4). 1206–1211. 14 indexed citations
6.
Dedrick, Robert L., et al.. (1973). Pharmacokinetics of 1-β-d-arabinofuranosylcytosine (Ara-C) deamination in several species. Biochemical Pharmacology. 22(19). 2405–2417. 92 indexed citations
7.
Frayha, George J., Samir Saheb, Gabriele Coppi, et al.. (1971). Index rerum vol. 16. Chemotherapy. 16(6). 405–408. 1 indexed citations
8.
Mellett, L.B., et al.. (1969). A useful thin-layer chromatography method for the determination of cytidine aminohydrolase activity in serum. Journal of Chromatography A. 43(3). 376–381. 5 indexed citations
9.
Zedeck, Morris S., L.B. Mellett, & Edward J. Cafruny. (1966). THE DIURETIC EFFECTS OF CYCLOPHOSPHAMIDE AND NORNITROGEN MUSTARD: RELATIONSHIP TO ANTIDIURETIC HORMONE. Journal of Pharmacology and Experimental Therapeutics. 153(3). 550–561. 7 indexed citations
10.
Hug, Carl C. & L.B. Mellett. (1965). TRITIUM-LABELED DIHYDROMORPHINE: ITS METABOLIC FATE AND EXCRETION IN THE RAT. Journal of Pharmacology and Experimental Therapeutics. 149(3). 446–453. 10 indexed citations
11.
Hug, Carl C., L.B. Mellett, & Edward J. Cafruny. (1965). STOP-FLOW ANALYSIS OF THE RENAL EXCRETION OF TRITIUM-LABELED DIHYDROMORPHINE. Journal of Pharmacology and Experimental Therapeutics. 150(2). 259–269. 8 indexed citations
12.
Mellett, L.B. & L.A. Woods. (1963). Analgesia and Addiction. Birkhäuser Basel eBooks. 5. 155–267. 13 indexed citations
13.
Mulé, S.J., L.A. Woods, & L.B. Mellett. (1962). DISTRIBUTION OF N-C14-METHYL LABELED MORPHINE: II. EFFECT OF NALORPHINE IN THE CENTRAL NERVOUS SYSTEM OF NONTOLERANT DOGS AND OBSERVATIONS ON METABOLISM. Journal of Pharmacology and Experimental Therapeutics. 136(2). 242–249. 15 indexed citations
14.
Mellett, L.B. & L.A. Woods. (1961). Excretion of Urinary N-C14-Methyl Morphine and Pulmonary C14O2 in the Monkey and Dog after Subcutaneous Injection of the Labelled Drug.. Experimental Biology and Medicine. 106(1). 221–223. 6 indexed citations
15.
Mellett, L.B. & L.A. Woods. (1960). The Fluorometric Estimation of Mechlorethamine (Mustargen) and Its Biological Disposition in the Dog. Cancer Research. 20(4). 518–523. 11 indexed citations
16.
Mellett, L.B. & L.A. Woods. (1960). The Comparative Physiological Disposition of ThioTEPA and TEPA in the Dog. Cancer Research. 20(4). 524–532. 55 indexed citations
17.
Mellett, L.B. & L.A. Woods. (1959). THE INTRACELLULAR DISTRIBUTION OF N-C14-METHYL LEVORPHANOL IN BRAIN, LIVER AND KIDNEY TISSUE OF THE RAT. Journal of Pharmacology and Experimental Therapeutics. 125(2). 97–104. 7 indexed citations
18.
Woods, L.A., et al.. (1958). THE SYNTHESIS AND ESTIMATION OF N-C14-METHYL LABELED LEVORPHANOL AND ITS BIOLOGICAL DISPOSITION IN THE MONKEY, DOG AND RAT. Journal of Pharmacology and Experimental Therapeutics. 124(1). 1–8. 8 indexed citations
19.
Mellett, L.B. & L.A. Woods. (1956). THE DISTRIBUTION AND FATE OF MORPHINE IN THE NON-TOLERANT AND TOLERANT MONKEY. Journal of Pharmacology and Experimental Therapeutics. 116(1). 77–83. 14 indexed citations
20.
Woods, L.A., et al.. (1956). PLASMA LEVELS AND EXCRETION OF CODEINE AND METABOLITES IN THE DOG AND MONKEY. Journal of Pharmacology and Experimental Therapeutics. 117(1). 117–125. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026